Several previously identified NAMPT inhibitors have shown efficacy in cancer models, including ovarian, colorectal, prostate, pancreatic, and non-small cell lung cancers, neuroblastoma, and fibrosarcoma [98]. Here, NAMPT is linked to cancer.